RE

Renalytix plc

  • CIK: 0001811115
  • EIN: 00-0000000
  • Business address: FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom, EC1V 9EE

Information

  • Mailing address
    FINSGATE, 5-7 CRANWOOD STREET, LONDON, Delaware, EC1V 9EE
  • Phone
    44 29 2071 0570
  • State location
    United Kingdom
  • State of incorporation
    Delaware
  • Fiscal year end
    June 30
  • SIC
    8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
  • Filings
    N/A

About Renalytix plc

Renalytix plc (CIK: 0001811115) is an American company incorporated in the state of United Kingdom. Head office is located at FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom, EC1V 9EE. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. Renalytix plc is a public company and trade via Over-The-Counter (OTC).

Old names:

  • Renalytix AI plc from 2020-15-May to 2021-25-Jun

Ownership

Owner Filings Transaction Date Type of Owner
Doran Howard JR 0001415965 Sep-01-2023 officer: Chief Business Officer
LEVANGIE DANIEL J 0001187406 Jul-01-2023 director
MCLAIN THOMAS H 0001206465 Jul-01-2023 officer: President
MILLS CHRISTOPHER 0001223129 Jul-01-2023 director, 10 percent owner
Scannell Timothy J 0001451533 Jul-01-2023 director
Coste Catherine 0001821432 Jul-01-2023 director
Sterling O. James 0001851144 Jul-01-2023 officer: Chief Financial Officer
MOUNT SINAI HEALTH SYSTEM, INC. 0001883135 Jul-01-2023 10 percent owner
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 0001883139 Jul-01-2023 10 percent owner
MOUNT SINAI HOSPITALS GROUP, INC. 0001885494 Jul-01-2023 10 percent owner
MOUNT SINAI HOSPITAL 0001899689 Jul-01-2023 10 percent owner
Fleming Fergus 0001973429 Jul-01-2023 director, officer: Chief Technical Officer
Parikh Chirag R. 0001973565 Jul-01-2023 director
Lium Erik 0001973569 Jul-01-2023 director
McCullough James Renwick 0001974146 Jul-01-2023 director, officer: Chief Executive Officer
Donovan Michael J. 0001975278 Jul-01-2023 officer: Chief Medical Officer

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Renalytix plc

Filings Format Description Filed/Effective File/Film Number
EFFECT Document Acc-no: 9999999995-25-002402 (33 Act) Size: KB Jul-30-2025

333-279966

251169093
EFFECT Document Acc-no: 9999999995-25-002400 (33 Act) Size: KB Jul-30-2025

333-278765

251169091
EFFECT Document Acc-no: 9999999995-25-002399 (33 Act) Size: KB Jul-30-2025

333-274733

251169090
EFFECT Document Acc-no: 9999999995-25-002398 (33 Act) Size: KB Jul-30-2025

333-271579

251169089
EFFECT Document Acc-no: 9999999995-25-002397 (33 Act) Size: KB Jul-30-2025

333-265280

251169087
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001193805-25-001128 (33 Act) Size: KB		 Jul-30-2025

333-239729

251167399
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0001213900-25-069259 (34 Act) Size: KB		 Jul-30-2025

001-39387

251166850
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001213900-25-068777 (33 Act) Size: KB		 Jul-29-2025

333-274733

251162726
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001213900-25-068773 (33 Act) Size: KB		 Jul-29-2025

333-279966

251162697
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001213900-25-068772 (33 Act) Size: KB		 Jul-29-2025

333-278765

251162686
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001213900-25-068769 (33 Act) Size: KB		 Jul-29-2025

333-271579

251162647
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001213900-25-068768 (33 Act) Size: KB		 Jul-29-2025

333-265280

251162634
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001213900-25-067774 (33 Act) Size: KB		 Jul-25-2025

333-274732

251152015
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001213900-25-067773 (33 Act) Size: KB		 Jul-25-2025

333-248741

251152014
SCHEDULE 13G/A Document Acc-no: 0001610520-25-000062 (34 Act) Size: KB Apr-30-2025

005-93440

25896170
SCHEDULE 13G/A Document Acc-no: 0001610520-25-000061 (34 Act) Size: KB Apr-30-2025

005-93440

25895436
SCHEDULE 13G Document Acc-no: 0001610520-25-000008 (34 Act) Size: KB Feb-10-2025

005-93440

25603949
8-K Document

Current report filing

Acc-no: 0001213900-25-004220 (34 Act) Size: KB		 Jan-16-2025

001-39387

25535991
8-K Document

Current report filing

Acc-no: 0001213900-24-111219 (34 Act) Size: KB		 Dec-20-2024

001-39387

241568406
DEF 14A Document

Definitive proxy statements

Acc-no: 0001213900-24-102087 (34 Act) Size: KB		 Nov-25-2024

001-39387

241495648

Recent 20 filings. View all Renalytix plc filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • Renalytix plc overview
  • Renalytix plc job
  • Renalytix plc stock
  • Renalytix plc ownership
  • Renalytix plc CEO
  • Renalytix plc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Lumexa Imaging Holdings, Inc.
Update: Nov 18, 2025
BillionToOne, Inc.
Update: Oct 08, 2025
Caris Life Sciences, Inc.
Update: May 24, 2025
GenEmbryomics Ltd
Update: Feb 21, 2025
Advanced Biomed Inc.
Update: May 23, 2023
Fortrea Holdings Inc.
Update: May 16, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4316 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3485 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3873 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4505 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2640 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2410 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1150 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4913 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3730 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by